Reports First Quarter Revenues of $11.6 Billion, an Increase of 5% YoY; or 7% When Adjusted for Foreign Exchange Posts First Quarter Earnings Per Share of $0.59 and Non-GAAP EPS of $1.96; Includes Net Impact of ($0.10) per share for GAAP and Non-GAAP EPS Due to Acquired IPRD1 Charges Partially Offset […]
Other News
Koya – Medical Device Innovations Company Launches Active Compression System for Lymphedema and Venous Disease – UCSF Rosenman Institute
Oakland, California, 2022-Apr-28 — /EPR Network/ — Koya Medical announced today that it commercially launched its Dayspring active compression system in the U.S. Oakland, California-based Koya designed the wearable Dayspring compression system to treat lymphedema and venous diseases in the lower extremities. It features a soft, breathable mesh garment with Koya’s proprietary Flexframe […]
FDA Clears Caretaker Medical’s Wireless Monitor for NonInvasive & Continuous Cardiac Output, Stroke Volume, and Advanced Hemodynamics
VitalStream™, Featuring Patented Pulse Decomposition Analysis™ technology becomes the World’s First Wireless Wearable Monitor for Continuous Blood Pressure and Advanced Hemodynamics – All with a single, easy-to-apply Finger Sensor Caretaker Medical, a digital health leader in continuous “beat by beat” wireless patient monitoring technologies, today announced that it has received […]
TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication
ANDOVER, Mass., April 28, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its OCS™ Heart System for […]
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company’s Amulet™ Device
First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., Abbott’s steerable sheath offers precise and flexible placement when used with the company’s Amplatzer Amulet LAA Occluder […]
Abiomed: Fiscal Q4 Earnings Snapshot
DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Thursday reported fiscal fourth-quarter net income of $60.3 million. The Danvers, Massachusetts-based company said it had profit of $1.31 per share. Earnings, adjusted for non-recurring gains and pretax gains, were $1.16 per share. The results exceeded Wall Street expectations. The average estimate […]
inHEART INITIATES RANDOMIZED CONTROLLED TRIAL FOR ITS AI-ENABLED DIGITAL TWIN OF THE HEART
A first-of-its-kind study comparing image-guided ventricular tachycardia (VT) ablation to conventional, catheter-based strategies to evaluate efficiency and efficacy of image-guided procedures in cardiac arrythmia patients. CAMBRIDGE, Mass. and PESSAC, France, April 28, 2022 /PRNewswire/ — inHEART Inc., a privately-held medical device company delivering the world’s most sophisticated, AI-enabled, digitally-rendered 3D models of the heart, announced […]
CardieX Announces Appointment of Lesa Musatto to its Board as an Independent, Non-Executive Director
Lesa brings 30 years of experience in marketing, product management, operations and sales to further diversify CardieX’s range of board members IRVINE, Calif., April 28, 2022 /PRNewswire/ — CardieX Limited (ASX: CDX), a global health technology company focused on cardiovascular disease and vascular health disorders, is pleased to announce the appointment of Lesa Musatto to its Board […]
iRhythm Technologies Announces Hiring of Dr. Mintu Turakhia as Chief Medical Officer and Chief Scientific Officer
SAN FRANCISCO, April 28, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Mintu Turakhia, M.D. M.A.S., will join iRhythm in the new role of Chief Medical Officer and Chief Scientific Officer. Dr. […]
LeMaitre Q1 2022 Financial Results
BURLINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q1 2022 Financial Results Sales of $39.6mm, +10% (+13% organic) vs. Q1 2021 Op. income of $7.9mm, +0% Op. margin of […]